Cocrystal Pharma Inc (NASDAQ:COCP)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - COCP

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - COCP

  • Market Cap$61.980m
  • SymbolNASDAQ:COCP
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS19188J3005

Company Profile

Cocrystal Pharma Inc is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). CC-31244 is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of a cocktail for ultra-short therapy of 4 to 6 weeks.Cocrystal Pharma Inc is a clinical stage biotechnology company developing novel antiviral therapeutics that target replication machinery of hepatitis viruses, influenza viruses, and noroviruses.

Latest COCP news

Currently there for this company. Visit our news hub for other news .